Señales en vivo de MBCI | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 abr 2024 @ 12:20):

Stats
Volumen de hoy	2 580.00
Volumen promedio	41.00
Capitalización de mercado	514 912
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2011-05-19	Berdugo Gad	Buy	200 000	Stock Option (Right to Buy)
2011-09-24	Berdugo Gad	Sell	120 000	Stock Option (Right to Buy)
2008-07-07	Katz Steven	Buy	0

INSIDER POWER
0.00
Last 2 transactions
Buy: 200 000 \| Sell: 120 000

Volumen Correlación

Largo: 0.03 (neutral)

Corto: 0.00 (neutral)

Signal:(37.716) Neutral

MabCure, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MabCure, Inc. Correlación - Moneda/Commodity

0.00
( neutral )

0.03
( neutral )

MabCure, Inc. Finanzas

Annual	2011
Ingresos:	$500 000
Beneficio Bruto:	$500 000 (100.00 %)
EPS:	$-0.198

FY	2011
Ingresos:	$500 000
Beneficio Bruto:	$500 000 (100.00 %)
EPS:	$-0.198

FY	2010
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.0200

Financial Reports:

No articles found.

MabCure, Inc.

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.